Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Healthcare Biotechnology
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more

Recent & Breaking News (TSX:AEZS)

Aeterna Zentaris Announces Virtual 2023 Meeting of Shareholders

GlobeNewswire May 15, 2023

Aeterna Zentaris Reports First Quarter 2023 Financial Results

GlobeNewswire May 9, 2023

Aeterna Zentaris Provides Update on Macrilen® (Macimorelin), Reiterates Advancement of Pediatric DETECT Trial

GlobeNewswire April 5, 2023

Aeterna Zentaris Reports Fourth Quarter and Full Year 2022 Financial Results

GlobeNewswire March 23, 2023

Pharmanovia to Market GHRYVELIN(TM) (Macimorelin) in the European Economic Area (EEA) and UK as Diagnostic Test for Growth Hormone Deficiency (GHD)

GlobeNewswire March 16, 2023

Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones

GlobeNewswire January 17, 2023

JTC Team to Host the Virtual Investor 2023 Companies to Watch Event on January 17th, 18th, and 19th

Accesswire January 11, 2023

Aeterna Zentaris to Present at the Virtual Investor 2023 Companies to Watch Event

GlobeNewswire January 10, 2023

Aeterna Zentaris Reports Third Quarter 2022 Financial Results

GlobeNewswire November 3, 2022

Aeterna Zentaris (TSX:AEZS) set to regain full rights to Macrilen in U.S. and Canada from Novo Nordisk

Azuka Onwuka August 29, 2022

Aeterna Zentaris Set to Regain Full Rights to Macrilen(TM) (Macimorelin) in U.S. and Canada from Novo Nordisk

GlobeNewswire August 29, 2022

Aeterna Zentaris Reports Second Quarter 2022 Financial Results and Recent Highlights

GlobeNewswire August 3, 2022

Aeterna Zentaris Announces Effective Date of Share Consolidation

GlobeNewswire July 18, 2022

Aeterna Zentaris Announces Shareholder Approval of Share Consolidation

GlobeNewswire July 15, 2022

Aeterna Zentaris Announces Further Adjournment of Shareholder Meeting

GlobeNewswire July 6, 2022

Aeterna Zentaris Announces Results of Annual Meeting of Shareholders

GlobeNewswire June 21, 2022

Aeterna Zentaris Achieves Proof-of-Concept for the Treatment of NMOSD with AIM Biologicals Program

GlobeNewswire June 13, 2022

Aeterna Zentaris to Present at the JMP Securities Life Sciences Conference

GlobeNewswire June 9, 2022

Aeterna Zentaris' Licensing Partner, Consilient Health Announces European Launch of Ghryvelin(TM) (macimorelin) for Diagnosing Adult Growth Hormone Deficiency

GlobeNewswire May 25, 2022

Aeterna Zentaris to Present at the H.C. Wainwright Global Investment Conference

GlobeNewswire May 18, 2022